cost saving estimates when effectively managing type 2 diabetes
Economic Costs of Diabetes in the U.S. in 2017
Diabetes Care. 2018 May;41(5):917-928.
(open access)
This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2017.
-
Estimated average annual medical expenditures attributed to diabetes
(total: institutional care, outpatient care, outpatient meds and supplies)-
$9,600 per person
-
Medical claim cost impact of improved diabetes control for Medicare and commercially insured patients with type 2 diabetes.
j manag care spec pharm. 2013 oct: 19(8) 609-620. (Open Access).
This article provides new information on the cost and event impact of better control for all 3 metrics (A1c, blood pressure, and lipids) for the commercial population and Medicare population separately .
Cost savings associated with
decreasing risk of complications – savings per patient per month
-
Decrease 1% A1c, 10 mmHg,
increase HDL 20%, decrease
cholesterol 20% =-
$66.73/mo Commercial
-
$58.85/mo Medicare
-
-
Decrease 1.25% A1c, 20
mmHg, increase HDL 35%,
decrease cholesterol 35% =-
$86.06/mo Commercial
-
$82.33/mo Medicare
-
-
Decrease 1.5% A1c, 30 mmHg, increase HDL 50%, decrease cholesterol 50% =
-
$105.47/mo Commercial
-
$106.04/mo Medicare
-